Signaling from mTOR to eIF2a mediates cell migration in response to the chemotherapeutic doxorubicin. (2019)

First Author: Harvey RF
Attributed to:  Post-transcriptional control of gene expression following toxic injury funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scisignal.aaw6763

PubMed Identifier: 31848319

Publication URI: http://europepmc.org/abstract/MED/31848319

Type: Journal Article/Review

Volume: 12

Parent Publication: Science signaling

Issue: 612

ISSN: 1945-0877